Variant report

Variant	esv3378090
Chromosome Location	chr4:56914220-56916768
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:56915544..56917169-chr4:56971414..56974217,2	K562	blood:
2	chr4:56914879..56917642-chr4:56927334..56929102,2	MCF-7	breast:
3	chr4:56914423..56917343-chr4:56954991..56956586,2	MCF-7	breast:
4	chr4:56910116..56913071-chr4:56914589..56916091,2	MCF-7	breast:
5	chr4:56732780..56733548-chr4:56914397..56915335,2	K562	blood:
6	chr4:56912197..56914161-chr4:56914438..56916191,2	MCF-7	breast:
7	chr4:56906651..56909346-chr4:56915136..56917400,3	MCF-7	breast:
8	chr4:56814506..56815307-chr4:56914802..56915691,3	K562	blood:
9	chr4:56902751..56905676-chr4:56913962..56916198,3	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000174799	chromatin interactions

Extended variants
information (count: 85 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:85 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs548833370	chr4:56914303-56914304	Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs367573525	chr4:56914335-56914336	Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs565674499	chr4:56914352-56914353	Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs534491916	chr4:56914353-56914354	Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs557970884	chr4:56914358-56914359	Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs373951351	chr4:56914363-56914364	Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs571360436	chr4:56914393-56914394	Active TSS Bivalent Enhancer Bivalent/Poised TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs7676365	chr4:56914418-56914419	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs182594946	chr4:56914433-56914434	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs530630110	chr4:56914501-56914502	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs542276849	chr4:56914508-56914509	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs556073695	chr4:56914510-56914511	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs116373722	chr4:56914521-56914522	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs541256315	chr4:56914522-56914523	Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs564662934	chr4:56914614-56914615	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs369451383	chr4:56914674-56914675	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs533365942	chr4:56914715-56914716	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs187572033	chr4:56914773-56914774	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs563256038	chr4:56914793-56914794	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs528844311	chr4:56914824-56914825	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs548600138	chr4:56914853-56914854	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs535601435	chr4:56914936-56914937	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs565637181	chr4:56915040-56915041	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs73155600	chr4:56915061-56915062	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs565954304	chr4:56915097-56915098	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs111995204	chr4:56915121-56915122	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs571389143	chr4:56915160-56915161	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs373452559	chr4:56915186-56915187	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs111543771	chr4:56915199-56915200	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs536866792	chr4:56915231-56915232	Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs556603288	chr4:56915241-56915242	Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs2412725	chr4:56915247-56915248	Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs535846763	chr4:56915250-56915251	Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs555838597	chr4:56915252-56915253	Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs572480511	chr4:56915282-56915283	Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs541664460	chr4:56915355-56915356	Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs558189902	chr4:56915396-56915397	Active TSS Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs192556418	chr4:56915428-56915429	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs578099498	chr4:56915457-56915458	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs543692077	chr4:56915519-56915520	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs113241227	chr4:56915588-56915589	Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs563024945	chr4:56915627-56915628	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs529004591	chr4:56915631-56915632	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs542320342	chr4:56915767-56915768	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
45	rs369913470	chr4:56915776-56915777	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
46	rs558872702	chr4:56915781-56915782	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
47	rs373148002	chr4:56915812-56915813	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs551617604	chr4:56915835-56915836	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs375884941	chr4:56915851-56915852	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs565065832	chr4:56915877-56915878	Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Glioblastoma multiforme	19435819	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian neoplasms	16753589	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Glioblastoma	17504929	CNVD
Glioblastoma	16823502	CNVD
Melanoma	16908931	CNVD
Glioblastoma	20031968	CNVD
Medulloblastoma	19270706	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Olfactory neuroblastoma	18408657	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Rhabdomyosarcoma	16790082	CNVD
Gastrointestinal stromal cancer	17438095	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	19208797	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	19115005	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	21138945	CNVD
Cancer	22183965	CNVD
Breast cancer	21785460	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:408 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:56908400-56914600	Weak transcription	GM12878-XiMat	blood
2	chr4:56909600-56914600	Weak transcription	Primary B cells from peripheral blood	blood
3	chr4:56914000-56914400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
4	chr4:56914000-56914400	Enhancers	Primary hematopoietic stem cells short term culture	blood
5	chr4:56914000-56914400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr4:56914000-56914400	Enhancers	Fetal Brain Male	brain
7	chr4:56914000-56914400	Enhancers	Fetal Brain Female	brain
8	chr4:56914000-56914800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
9	chr4:56914000-56916800	Active TSS	H1 Cell Line	embryonic stem cell
10	chr4:56914000-56917000	Active TSS	Cortex derived primary cultured neurospheres	brain
11	chr4:56914000-56917200	Active TSS	ES-I3 Cell Line	embryonic stem cell
12	chr4:56914200-56914400	Active TSS	HUES48 Cell Line	embryonic stem cell
13	chr4:56914200-56914400	Enhancers	Primary hematopoietic stem cells	blood
14	chr4:56914200-56914400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
15	chr4:56914200-56914600	Enhancers	Brain Germinal Matrix	brain
16	chr4:56914200-56917000	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
17	chr4:56914200-56917200	Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
18	chr4:56914200-56917400	Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
19	chr4:56914400-56914600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
20	chr4:56914400-56914600	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr4:56914400-56914600	Bivalent Enhancer	Primary B cells from cord blood	blood
22	chr4:56914400-56914600	Bivalent Enhancer	Fetal Heart	heart
23	chr4:56914400-56914600	Enhancers	Fetal Intestine Small	intestine
24	chr4:56914400-56914600	Bivalent/Poised TSS	HepG2	liver
25	chr4:56914400-56914600	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
26	chr4:56914400-56914600	Bivalent Enhancer	Osteobl	bone
27	chr4:56914400-56914800	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
28	chr4:56914400-56914800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
29	chr4:56914400-56914800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
30	chr4:56914400-56914800	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
31	chr4:56914400-56914800	Flanking Active TSS	Fetal Brain Female	brain
32	chr4:56914400-56914800	Active TSS	Rectal Mucosa Donor 29	rectum
33	chr4:56914400-56915000	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
34	chr4:56914400-56915000	Flanking Active TSS	Fetal Brain Male	brain
35	chr4:56914400-56915200	Flanking Active TSS	Primary hematopoietic stem cells	blood
36	chr4:56914400-56915200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
37	chr4:56914400-56915200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
38	chr4:56914400-56915200	Flanking Active TSS	HUVEC	blood vessel
39	chr4:56914400-56917000	Active TSS	ES-WA7 Cell Line	embryonic stem cell
40	chr4:56914400-56917200	Active TSS	Brain Substantia Nigra	brain
41	chr4:56914400-56917400	Active TSS	Pancreatic Islets	Pancreatic Islet
42	chr4:56914400-56917800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
43	chr4:56914600-56914800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
44	chr4:56914600-56914800	Bivalent/Poised TSS	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr4:56914600-56914800	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr4:56914600-56914800	Flanking Bivalent TSS/Enh	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr4:56914600-56914800	Enhancers	Breast Myoepithelial Primary Cells	Breast
48	chr4:56914600-56914800	Flanking Bivalent TSS/Enh	Primary B cells from cord blood	blood
49	chr4:56914600-56914800	Enhancers	Primary B cells from peripheral blood	blood
50	chr4:56914600-56914800	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links